Navigation Links
Research shows single-patient rooms reduce hospital infections in ICU
Date:1/11/2011

This release is available in French.

Montreal, January 10, 2011 A research team from the McGill University Health Centre (MUHC) and McGill University has demonstrated that private rooms in the Intensive Care Unit (ICU) play a key role in reducing hospital infections like C-difficile. The study, published today in the journal Archives of Internal Medicine, also suggests that length of stay would be shorter and this could lead to cost savings to the healthcare system.

Infection control in hospitals is a worldwide health concern that can have a serious impact on patient morbidity, mortality and the cost of treatment particularly in the ICU, where patients are highly susceptible to infection. Single-patient rooms have long been considered to provide patients with better protection from hospital infections. However, previous studies investigating this issue have been inconclusive. "We had a valuable opportunity to examine the rates of acquisition of infection in patients during a change from multi-bed to single rooms in the ICU at the MUHC," explains Dana Teltsch, lead author of the study and Ph.D. candidate in the Dept. of Epidemiology, Biostatistics and Occupational Health at McGill.

The results show that the infection acquisition rate after room privatization fell about 50 percent for three bacteria of most concern Staphylococcus aureus (MRSA), C-difficile and Enterococcus (VRE). "We also observed a 10 percent reduction in the length of stay in the ICU after changing to private rooms. These findings provide a basis of comparison of the savings versus the costs to the healthcare system on top of the health benefits to patients," said Teltsch. It is estimated each case of C. difficile can cost of up to $7000 per episode.

"This study is the first evaluation of the full range of the benefits of private rooms in an ICU environment and highlights the important role that physical infrastructure plays in the prevention of transmission of healthcare associated pathogens," said Dr. Vivian Loo, one the co-author's of the study, Chief of Microbiology at the MUHC and Associate Professor in McGill's Department of Medicine. "Of course, other factors are also important in preventing transmission, like hand hygiene, isolation precautions, antibiotic stewardship and housekeeping practices, but this study clearly demonstrates the crucial need for private rooms, particularly for this patient population."

"Private rooms can help our patients avoid infections and also aid the healthcare system as a whole in decreasing length of stay associated with hospital-acquired infections," says Dr. David Buckeridge, senior author, Associate Professor in the Dept. of Epidemiology, Biostatistics and Occupational Health at McGill and a Medical Scientist in the Department of Medicine at the Research Institute of the MUHC. "We did not measure all of the costs and benefits of private rooms in our study, but they are an investment that, once built, should continue to provide substantial benefit."

All rooms at the New MUHC, at the Glen, Lachine and Mountain campuses, will be single-patient rooms where natural light, a comfortable family area, and a private bathroom will contribute to the healing of both body and mind. Apart from limiting the spread of infections, single-patient rooms ensure privacy and confidentiality, give patients a sense of control and provide enough space for medical equipment to be wheeled in beside beds, meaning that patients can stay in their rooms for routine exams, treatments or tests.


'/>"/>

Contact: Julie Robert
julie.robert@muhc.mcgill.ca
514-843-1560
McGill University Health Centre
Source:Eurekalert

Related biology news :

1. AAAS honors Iowa State, Ames Lab researchers for distinguished science
2. New research aims to shut down viral assembly line
3. Researchers brave icy waters to study Arctic food web
4. Carnegie Mellon researchers identify Facebook neurons
5. Symposium to provide forum for best pre-clinical and translational bone research
6. Researchers create scoring system for PTEN mutation testing
7. Researchers show how Alzheimers plaques lead to loss of nitric oxide in brain
8. Research identifies drug target for prion diseases, mad cow
9. Mayo researchers describe measles viral protein movement
10. Increasing diversity of future life science researchers
11. Biofuel grasslands better for birds than ethanol staple corn, researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... , Feb. 7, 2017 The biometrics ... by the confluence of organizations, desires to better ... knowledge-based systems (password and challenge questions), biometrics is ... government systems. The market is driven by use ... between consumer and enterprise uses cases, with consumer-facing ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... ... February 22, 2017 , ... ProMIS Neurosciences (“ProMIS” or ... neurodegenerative diseases, today announced it has issued a scientific white paper entitled “Results ... a series of commentaries from ProMIS’s scientific team offering insight into the Company’s ...
(Date:2/22/2017)... ... February 22, 2017 , ... LabRoots , the leading provider of educational ... is pleased to announce the launch of a new scholarship for young scientists seeking ... This merit-based scholarship is open to all high school seniors, 17 years or older; ...
(Date:2/22/2017)... , Feb. 22, 2017 Origin (Origin Agritech, LLC, ... trait and seed provider, and Arcadia (Arcadia ... that develops and commercializes agricultural productivity traits and nutritional products, today ... corn biotechnology product developed in China to ... regulatory trials. ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... that Dr. Daniel Spyker, PhD, MD former Acting Deputy Director in the FDA ... Pilot Drug Evaluation Staff has joined the company as an Expert Consultant. , ...
Breaking Biology Technology: